UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 618

Sortiert nach

Clinical Features of Temporal Epilepsy with Involvement of the Insular Lobe

Neuroscience and behavioral physiology, 2022-03, Vol.52 (3), p.356-361

2022

Volltextzugriff (PDF)

Diagnostic evaluation of drug-resistant insular epilepsy

Èpilepsiâ i paroksizmalʹnye sostoâniâ (Online), 2019-03, Vol.10 (4), p.83-93

2019

Volltextzugriff (PDF)

Drug provision and health technology assessment in France

Farmakoèkonomika (Moskva. Online), 2020-04, Vol.13 (1), p.71-83

2020

Volltextzugriff (PDF)

Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy

Farmakoèkonomika (Moskva. Online), 2021-04, Vol.14 (1), p.5-15

2021

Volltextzugriff (PDF)

The health technology assessment system in Australia

Farmakoèkonomika (Moskva. Online), 2020-02, Vol.12 (4), p.333-341

2020

Volltextzugriff (PDF)

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871

Farmakoèkonomika (Moskva. Online), 2020-08, Vol.13 (2), p.113-123

2020

Volltextzugriff (PDF)

Health technology assessment and reimbursement of pharmaceuticals in Italy

Farmakoèkonomika (Moskva. Online), 2019-07, Vol.12 (2), p.156-164

2019

Volltextzugriff (PDF)

Organizational structure and funding of health technology assessment agencies around the world

Farmakoèkonomika (Moskva. Online), 2019-07, Vol.12 (2), p.146-154

2019

Volltextzugriff (PDF)

Surgical treatment of drug resistant epilepsy in Sturge-Weber syndrome: review of the literature and clinical case presentation

Èpilepsiâ i paroksizmalʹnye sostoâniâ (Online), 2019-04, Vol.11 (1), p.53-62

2019

Volltextzugriff (PDF)

COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY

Farmakoèkonomika (Moskva. Online), 2017-03, Vol.9 (4), p.46-53

2017

Volltextzugriff (PDF)

Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan

Farmakoèkonomika (Moskva. Online), 2019-05, Vol.12 (1), p.14-26

2019

Volltextzugriff (PDF)

Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

Value in health, 2015-11, Vol.18 (7), p.A509-A509

2015

Volltextzugriff (PDF)

Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies: Methodology and Preliminary Results

Value in health, 2015-11, Vol.18 (7), p.A701-A701

2015

Volltextzugriff (PDF)

Translation into Russian and Validation of the Cochrane Questionnarie to Assess Risks of Systematic Biases in Randomized Controlled Trials

Value in health, 2015-11, Vol.18 (7), p.A724-A724

2015

Volltextzugriff (PDF)

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

Farmakoèkonomika (Moskva. Online), 2017-08, Vol.10 (2), p.69-74

2017

Volltextzugriff (PDF)

Review of the current approaches to the assessment of the drug innovative potential worldwide

Farmakoèkonomika (Moskva. Online), 2017-11, Vol.10 (3), p.66-74

2017

Volltextzugriff (PDF)

CLINICAL AND ECONOMIC ANALYSIS OF ALTERNATIVE SCHEMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C GENOTYPE 1 IN PATIENTS WHO DID NOT ANSWER TO THE PRIOR THERAPY, IN THE RUSSIAN FEDERATION

Ėksperimental'nai͡a︡ i klinicheskai͡a︡ gastroėnterologii͡a, 2015 (3), p.55

2015

Volltextzugriff (PDF)

PCN143 - Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

Value in health, 2016-11, Vol.19 (7), p.A734-A734

2016

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

Value in health, 2016-11, Vol.19 (7), p.A734-A734

2016

Volltextzugriff (PDF)

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA

Farmakoèkonomika (Moskva. Online), 2016-04, Vol.9 (1), p.3-14

2016

Volltextzugriff (PDF)

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA

Farmakoèkonomika (Moskva. Online), 2016-01, Vol.9 (1), p.3-14

2016

Volltextzugriff (PDF)

PRM236 - Translation into Russian and Validation of the Cochrane Questionnarie to Assess Risks of Systematic Biases in Randomized Controlled Trials

Value in health, 2015-11, Vol.18 (7), p.A724-A724

2015

Volltextzugriff (PDF)

PUK10 - Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

Value in health, 2015-11, Vol.18 (7), p.A509-A509

2015

Volltextzugriff (PDF)

PRM103 - Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies: Methodology and Preliminary Results

Value in health, 2015-11, Vol.18 (7), p.A701-A701

2015

Volltextzugriff (PDF)

MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN

Farmakoèkonomika (Moskva. Online), 2015-03, Vol.7 (3), p.12-19

2015

Volltextzugriff (PDF)

1 – 25 von 618

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(579)
Mit Volltextzugriff
(597)

Publikationsform

Artikel
(617)
Tagungsberichte
(1)

Sprache

Englisch
(612)
Japanisch
(24)
Russisch
(20)

Erscheinungsjahr

n.n

Thema

Physics
(337)
Science & Technology
(193)
Physical Sciences
(162)
Elementary Particles
(158)
Physics And Astronomy
(145)
Quantum Field Theory
(136)
Quantum Field Theories
(128)
String Theory
(128)
High Energy Physics - Experiment
(121)
High Energy Physics
(107)
Quantum Physics
(101)
Classical And Quantum Gravitation
(100)
Relativity Theory
(100)
Collisions
(95)
Large Hadron Collider
(90)
Luminosity
(87)
Solenoids
(80)
Physics, Particles & Fields
(66)
Physics Of Elementary Particles And Fields
(65)
Physics, Multidisciplinary
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Clinical Features of Temporal Epilepsy with Involvement of the Insular Lobe

Diagnostic evaluation of drug-resistant insular epilepsy

Drug provision and health technology assessment in France

Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy

The health technology assessment system in Australia

Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871

Health technology assessment and reimbursement of pharmaceuticals in Italy

Organizational structure and funding of health technology assessment agencies around the world

Surgical treatment of drug resistant epilepsy in Sturge-Weber syndrome: review of the literature and clinical case presentation

COMPARISON OF RECOMMENDED SCREENING PROGRAMS IN THE UNITED STATES, CANADA, THE NETHERLANDS AND GERMANY

Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan

Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies: Methodology and Preliminary Results

Translation into Russian and Validation of the Cochrane Questionnarie to Assess Risks of Systematic Biases in Randomized Controlled Trials

THE USE OF MULTI-CRITERIAL DECISION ANALYSIS (MCDA) FOR ESTIMATING THE THERAPEUTIC VALUE OF INNOVATIVE DRUGS

Review of the current approaches to the assessment of the drug innovative potential worldwide

CLINICAL AND ECONOMIC ANALYSIS OF ALTERNATIVE SCHEMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS C GENOTYPE 1 IN PATIENTS WHO DID NOT ANSWER TO THE PRIOR THERAPY, IN THE RUSSIAN FEDERATION

PCN143 - Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

Cost-Effectiveness Analysis of Brentuximab Vedotin in Adults with Relapsed or Refractory Hodgkin’s Lymphoma

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA

PRM236 - Translation into Russian and Validation of the Cochrane Questionnarie to Assess Risks of Systematic Biases in Randomized Controlled Trials

PUK10 - Costs Of Overactive Bladder Symptoms Treatment With Solifenacin

PRM103 - Quantitative Assessment of Therapeutic Value of Innovative Medical Technologies: Methodology and Preliminary Results

MODELI NG CLINICAL AND ECONOMIC OUTCOMES OF TESTING FOR LTBI WITH T-SPOT.TB IN IMMUNOCOMPROMISED CHILDREN

Suchergebnisse filtern